Filing Flows › Medpace Holdings (MEDP) › Q1 2025
Medpace Holdings (MEDP) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 22, 2025
Medpace Holdings (MEDP) reported revenue of $559M for the first quarter 2025 (Q1 2025), +9% from a year earlier and +4% from the quarter before. Operating margin was 20.3%, net earnings $115M (20.5% of revenue).
Medpace Holdings, Q1 2025: revenue $559M (+9% year over year), operating margin 20.3%, net earnings $115M, operating cash flow $126M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $559M | +4% | +9% |
| Operating profit | $114M | -9% | +9% |
| Net earnings | $115M | -2% | +12% |
| Operating cash flow | $126M | -34% | -18% |
| Free cash flow | $116M | -37% | -21% |
What changed
Revenue was $558.6M in Q1 2025, up 9% year over year and up 4% from the previous quarter. Oncology was the largest line at 31% of revenue. Metabolic added $44.4M year over year (up 43%), 93% of the total change. AVAI declined 29%.
Operating profit was $113.5M, a 20.3% margin (unchanged year over year). Of the extra revenue versus a year earlier, 20% reached operating profit, below the 20% margin then. Total costs grew 9% against revenue growth of 9%. The fastest-growing cost line was SG&A (+31%). Net earnings were $114.6M, up 12% year over year. The effective tax rate was 3.0%.
Operating cash flow was $125.8M (down 18% year over year), 110% of net earnings. Non-cash charges added back $6.9M of depreciation and amortization and $16.9M of share-based compensation. Working capital and other items used $12.6M. Capital expenditures of $10.0M left free cash flow of $115.8M.
Questions
What was Medpace Holdings' revenue in the first quarter 2025?
Medpace Holdings (MEDP) reported revenue of $559M for the first quarter 2025 (Q1 2025), +9% from a year earlier and +4% from the quarter before.
Was Medpace Holdings profitable in the first quarter 2025?
Operating profit was $114M (20.3% of revenue) and net earnings $115M.
Source: Medpace Holdings 10-Q on SEC EDGAR.